Skip to main navigation Skip to search Skip to main content

Open-Label, Observational, Prospective Study of Cognitive Impairment and Vocational Status in Fingolimod (Gilenya) Treated Patients: Identifying Clinically Meaningful Change

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/13 → 12/31/22

Funding

  • Novartis Pharmaceuticals Corporation: $141,317.00